Detalhe da pesquisa
1.
Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.
Oncologist
; 27(12): 1041-1047, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35979929
2.
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.
Lancet Oncol
; 20(4): 581-590, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30827746
3.
Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146.
Eur Urol
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38777648